Please log in
You must be logged in to send the contact request.
Manage stand orders
Select Option
Shanghai Fosun Long March Medical Scienc Med-Tech Development Co., Ltd.
No. 830 Chengyin Road Baoshan District,
200444
Shanghai
China
China
Telephone +86 21 60765718
Fax +86 21 60765999
diagnostics@fosunpharma.com
http://en.lm-diagnostics.com.cn/
Fax +86 21 60765999
diagnostics@fosunpharma.com
http://en.lm-diagnostics.com.cn/
Submit your contact details
Provide your contact details to the exhibitor. Optionally, you may also add a personal message.
An error has occurred
Please check your internet connection or try again later.
Message has been sent
Your message to the exhibitor was sent successfully.
Contact
Our range of products
Product categories
- 03 Diagnostic tests
- 03.01 Clinical chemistry
- 03.01.01 Glucose testing
Glucose testing
- 03 Diagnostic tests
- 03.02 Immunochemistry testing, immunology testing
- 03.02.01 Immuno assay testing
Immuno assay testing
- 03 Diagnostic tests
- 03.02 Immunochemistry testing, immunology testing
- 03.02.02 Diagnostic rapid tests
Diagnostic rapid tests
- 03 Diagnostic tests
- 03.04 Microbiology testing
- 03.04.01 Bacteriology testing in microbiology
Bacteriology testing in microbiology
- 03 Diagnostic tests
- 03.06 Genetic testing, molecular diagnostics
- 03.06.03 Polymerase chain reaction (PCR)
Polymerase chain reaction (PCR)
- Novel Coronavirus (2019-nCoV) RT-PCR Detection Kit
- FluA/FluB/2019-nCoV RT-PCR Detection Kit
- Novel Coronavirus (2019-nCoV) Real-time Isothermal Amplification Kit
- Respiratory syncytial virus Real-time Isothermal Amplification Kit
- Chlamydia pneumonia/Mycoplasma pneumoniae Real-time Isothermal Amplification Kit
- Novel Coronavirus(2019-nCoV) IgM/IgG Test Kit
Our products
Product category: Polymerase chain reaction (PCR)
Novel Coronavirus (2019-nCoV) RT-PCR Detection Kit
Features
• 3 target detection
qualitative detection of ORF1ab gene, N gene and E gene, reduce recheck and improve detection efficiency.
• Fully automatic extraction
with rapid nucleic acid extractor and extraction reagent, the nucleic acid can be extracted and purified quickly and safely, and the detection of 96 samples can be completed in 2 hours.
• Full-process internal monitoring
internal control were used to effectively monitor the whole detection process of extraction, reverse transcription and amplification, to avoid false negative results.
• Anti-contamination system
UNG enzyme and dUTP were used to effectively prevent the contamination of PCR amplicon, to avoid false positive results.
• 3 target detection
qualitative detection of ORF1ab gene, N gene and E gene, reduce recheck and improve detection efficiency.
• Fully automatic extraction
with rapid nucleic acid extractor and extraction reagent, the nucleic acid can be extracted and purified quickly and safely, and the detection of 96 samples can be completed in 2 hours.
• Full-process internal monitoring
internal control were used to effectively monitor the whole detection process of extraction, reverse transcription and amplification, to avoid false negative results.
• Anti-contamination system
UNG enzyme and dUTP were used to effectively prevent the contamination of PCR amplicon, to avoid false positive results.
Product category: Polymerase chain reaction (PCR)
FluA/FluB/2019-nCoV RT-PCR Detection Kit
Features
• Multiple pathogen detection:
the 2019-nCOV (ORF1ab and N genes) can be distinguished with Flu A/ Flu B simultaneously. Considering that it is also a period of high incidence of influenza, the detection test which is more comprehensive can not only be used for the differential diagnosis of suspected cases, but also can be used for the diagnosis of whether the patients have 2019-nCOV with Flu A/ Flu B coinfection, providing basis for clinical treatment.
• High sensitivity:
300 copies/mL, to prevent missed detection to the greatest extent.
• Full-process internal monitoring:
internal control were used to effectively monitor the whole detection process of extraction, reverse transcription and amplification, to avoid false negative results.
• Anti-contamination system
UNG enzyme and dUTP were used to effectively prevent the contamination of PCR amplicon, to avoid false positive results.
• Multiple pathogen detection:
the 2019-nCOV (ORF1ab and N genes) can be distinguished with Flu A/ Flu B simultaneously. Considering that it is also a period of high incidence of influenza, the detection test which is more comprehensive can not only be used for the differential diagnosis of suspected cases, but also can be used for the diagnosis of whether the patients have 2019-nCOV with Flu A/ Flu B coinfection, providing basis for clinical treatment.
• High sensitivity:
300 copies/mL, to prevent missed detection to the greatest extent.
• Full-process internal monitoring:
internal control were used to effectively monitor the whole detection process of extraction, reverse transcription and amplification, to avoid false negative results.
• Anti-contamination system
UNG enzyme and dUTP were used to effectively prevent the contamination of PCR amplicon, to avoid false positive results.
Product category: Polymerase chain reaction (PCR)
Novel Coronavirus (2019-nCoV) Real-time Isothermal Amplification Kit
Features
• 2 target detection
qualitative detection of ORF1ab gene and N gene.
• High sensitivity
1000 copies/mL, to prevent missed detection to the greatest extent.
• Rapid detection
using Loop-mediated isothermal amplification (LAMP) which has the characteristics of high sensitivity, high specificity and rapid detection of POCT in order to achieve rapid detection of 2019-nCOV.
• Full-process internal monitoring
internal control were used to effectively monitor the whole detection process of extraction, reverse transcription and amplification, to avoid false negative results.
• 2 target detection
qualitative detection of ORF1ab gene and N gene.
• High sensitivity
1000 copies/mL, to prevent missed detection to the greatest extent.
• Rapid detection
using Loop-mediated isothermal amplification (LAMP) which has the characteristics of high sensitivity, high specificity and rapid detection of POCT in order to achieve rapid detection of 2019-nCOV.
• Full-process internal monitoring
internal control were used to effectively monitor the whole detection process of extraction, reverse transcription and amplification, to avoid false negative results.
Product category: Polymerase chain reaction (PCR)
Respiratory syncytial virus Real-time Isothermal Amplification Kit
Features
• 2 target detection
the subtypes A and B of RSV which are the pathogens that cause the most community acquired pneumonia in children can be detected respectively
• High sensitivity
1000 copies/m
• Rapid detection
using Loop-mediated isothermal amplification (LAMP) which has the characteristics of high sensitivity, high specificity and rapid detection of POCT in order to achieve rapid detection of RSV.
• Full-process internal monitoring
internal control were used to effectively monitor the whole detection process of extraction, reverse transcription and amplification, to avoid false negative results.
• 2 target detection
the subtypes A and B of RSV which are the pathogens that cause the most community acquired pneumonia in children can be detected respectively
• High sensitivity
1000 copies/m
• Rapid detection
using Loop-mediated isothermal amplification (LAMP) which has the characteristics of high sensitivity, high specificity and rapid detection of POCT in order to achieve rapid detection of RSV.
• Full-process internal monitoring
internal control were used to effectively monitor the whole detection process of extraction, reverse transcription and amplification, to avoid false negative results.
Product category: Polymerase chain reaction (PCR)
Chlamydia pneumonia/Mycoplasma pneumoniae Real-time Isothermal Amplification Kit
Features:
• 2 target detection
Mycoplasma pneumoniae and Chlamydia pneumoniae that cause atypical pneumonia can be detected respectively.
• High sensitivity
1000 copies/mL
• Rapid detection
using Loop-mediated isothermal amplification (LAMP) which has the characteristics of high sensitivity, high specificity and rapid detection of POCT in order to achieve rapid detection of Mycoplasma pneumoniae and Chlamydia pneumoniae.
• Full-process internal monitoring
internal control were used to effectively monitor the whole detection process of extraction, reverse transcription and amplification, to avoid false negative results.
• 2 target detection
Mycoplasma pneumoniae and Chlamydia pneumoniae that cause atypical pneumonia can be detected respectively.
• High sensitivity
1000 copies/mL
• Rapid detection
using Loop-mediated isothermal amplification (LAMP) which has the characteristics of high sensitivity, high specificity and rapid detection of POCT in order to achieve rapid detection of Mycoplasma pneumoniae and Chlamydia pneumoniae.
• Full-process internal monitoring
internal control were used to effectively monitor the whole detection process of extraction, reverse transcription and amplification, to avoid false negative results.
Product category: Polymerase chain reaction (PCR)
Novel Coronavirus(2019-nCoV) IgM/IgG Test Kit
Features:
• Multiple antibody detection
antibodies IgM and IgG of 2019-nCOV can be detected simultaneously to make the detection more comprehensive.
• Immunofluorescence assay
better sensitivity and specificity than colloidal gold assay.
• Simple operation
suitable for community hospital, cost only 15 minutes to report the results.
• Internal quality control line
monitor whether the test results are effective.
• Limitations of detection
due to the window period of antibody production, it needs to be interpreted together with nucleic acid detection results.
• Multiple antibody detection
antibodies IgM and IgG of 2019-nCOV can be detected simultaneously to make the detection more comprehensive.
• Immunofluorescence assay
better sensitivity and specificity than colloidal gold assay.
• Simple operation
suitable for community hospital, cost only 15 minutes to report the results.
• Internal quality control line
monitor whether the test results are effective.
• Limitations of detection
due to the window period of antibody production, it needs to be interpreted together with nucleic acid detection results.
Company news
Date
Topic
Download
Nov 16, 2020
FOSUN COVID- 19 RT PCR KITS with approval by WHO EUL and FDA EUA ---FIGHT COVID-19 together with FOSUN GLOBALLY
Dear Sirs/Madam
Since the outbreak of the coronavirus pandemic, Fosun has actively participated in the fight against the epidemic in China and around the world, and has joined hands to provide assistance to the world. Fosun has been accelerating in its businesses of research and development of diagnostic reagents and vaccines related to COVID-19, which have obtained urgent approval from the National Medical Products Administration and the CE certification and FDA EUA and also listed in WHO website with WHO EUL respectively, and have been exported as donations or products sold to overseas countries, including South Korea, Portugal, Hungary, Germany and Indonesia.
The ceritificate and approval has been obtained by Fosun Covid-19 RT PCR Detection kit.
✔️ Chinese NMPA
✔️ CE
✔️ FDA EUA
✔️ WHOEUL
✔️ WHO PQ
✔️ BRAZIL ANVISA
✔️ SINGAPORE HSA
✔️ AUSTRALIA TGA
✔️ INDIA
Attached is the presentation of FOSUN COVID-19 RT PCR TEST KITS. Feel free to contact us.
Since the outbreak of the coronavirus pandemic, Fosun has actively participated in the fight against the epidemic in China and around the world, and has joined hands to provide assistance to the world. Fosun has been accelerating in its businesses of research and development of diagnostic reagents and vaccines related to COVID-19, which have obtained urgent approval from the National Medical Products Administration and the CE certification and FDA EUA and also listed in WHO website with WHO EUL respectively, and have been exported as donations or products sold to overseas countries, including South Korea, Portugal, Hungary, Germany and Indonesia.
The ceritificate and approval has been obtained by Fosun Covid-19 RT PCR Detection kit.
✔️ Chinese NMPA
✔️ CE
✔️ FDA EUA
✔️ WHOEUL
✔️ WHO PQ
✔️ BRAZIL ANVISA
✔️ SINGAPORE HSA
✔️ AUSTRALIA TGA
✔️ INDIA
Attached is the presentation of FOSUN COVID-19 RT PCR TEST KITS. Feel free to contact us.
About us
Company details
Established in 1989, Shanghai Fosun Long March Medical Science Co.,Ltd (herein after as Fosun Long March) is a high tech in-vitro diagnostics enterprise who is active in manufacturing, marketing and research and development of diagnostic and laboratory instrument and reagent. At the moment, Shanghai Fosun Long March Medical Science Co., Ltd is a wholly owned company by Shanghai Fosunpharma (Group), a China Fortune 500 company.
With product range from Clinical Chemistry kits, ELISA kits, Immunoturbidimetry kits , blood gas to electrolyte analyzer kits, we become one of the most influential brands in in-vitro diagnostics area. Our national wide sales network provides our customers products with good reputation. Being quick and efficient, our after-sales service network meets the demand of our customers whom spread throughout the country. Our products are manufactured under GMP and ISO13485 certification.
We have approximately 500 employees in the company. Fosun Long March has been rewarded with prizes by Ministry of Health, Shanghai Science and Technical Committee and Industry Associations. Also Fosun Long March has been recognized as 'High-Tech Enterprise' by Shanghai Government.
As the investment platform of IVD division of FosunPharma Group, Fosun Long March has speeded up merger and acquisition in the centre of new product introduction. We directly hold Yaneng Biosciences (Shenzhen) Co., Ltd, Shanghai Fosun Med-Tech Development Co., Shanghai Biofosun Biotech Co., Ltd and Jiangsu Star Diagnostics Co.,Ltd. We partly hold SINNOWA Medical Science & Technology Co., LTD and Steellex Scientific Instrument Company. At the same time, we also have close cooperation with Saladax USA, and SDB Korea through FosunPharma.
Currently the company has obtained CFDA approval for a hundred products, and more than ten patents. The imported product T-spot TB, as only authorized tuberculosis diagnosis kits in China market, filled the gaps in this field for domestic market.
Fosun Long March strives to be the leading provider of in-vitro diagnostics solutions in China. We will continue our research and development, introduction of advanced technology and cooperation with research institute in future.
With product range from Clinical Chemistry kits, ELISA kits, Immunoturbidimetry kits , blood gas to electrolyte analyzer kits, we become one of the most influential brands in in-vitro diagnostics area. Our national wide sales network provides our customers products with good reputation. Being quick and efficient, our after-sales service network meets the demand of our customers whom spread throughout the country. Our products are manufactured under GMP and ISO13485 certification.
We have approximately 500 employees in the company. Fosun Long March has been rewarded with prizes by Ministry of Health, Shanghai Science and Technical Committee and Industry Associations. Also Fosun Long March has been recognized as 'High-Tech Enterprise' by Shanghai Government.
As the investment platform of IVD division of FosunPharma Group, Fosun Long March has speeded up merger and acquisition in the centre of new product introduction. We directly hold Yaneng Biosciences (Shenzhen) Co., Ltd, Shanghai Fosun Med-Tech Development Co., Shanghai Biofosun Biotech Co., Ltd and Jiangsu Star Diagnostics Co.,Ltd. We partly hold SINNOWA Medical Science & Technology Co., LTD and Steellex Scientific Instrument Company. At the same time, we also have close cooperation with Saladax USA, and SDB Korea through FosunPharma.
Currently the company has obtained CFDA approval for a hundred products, and more than ten patents. The imported product T-spot TB, as only authorized tuberculosis diagnosis kits in China market, filled the gaps in this field for domestic market.
Fosun Long March strives to be the leading provider of in-vitro diagnostics solutions in China. We will continue our research and development, introduction of advanced technology and cooperation with research institute in future.
Company data
Sales volume50-99 Mio US $
Export contentmax. 50%
Number of employees100-499
Area of businessDiagnostics